LIPID PEROXIDATION AND THE LEVEL OF FREE FATTY ACIDS IN PATIENTS WITH DIABETES 2ND TYPE IN INSULIN THERAPY AND INTENSIVE GLYCEMIC CONTROL IN ACUTE PHASE OF MYOCARDIAL INFARCTION

Aim. To compare the efficacy of infusion and traditional pharmacological correction of carbohydrate metabolism in acute period of myocardial infarction (MI) in patients with diabetes 2nd type (DM2), to assess the intensiveness of oxidative stress and free fatty acids level in the groups of patients included. Material and methods. Totally 92 patients included with MI, of those 52 with DM2. Anamnesis of DM2 and glycemia level >10 mmol/L were randomized into I group (n=26) with intravenous infusion insulin therapy (IIT) and intensive glycemia control (IGC) by the protocol developed. Into II group we randomized 26 patients with traditional DM2 therapy that could include insulin too. IIT protocol in MI in DM2 patients was aimed to reach the exact glycemia level during exact time period with intravenous insulin load. During the 1st day target values of glucose were 10-7,8 mmol/L, for 2nd and 3rd days <8,3 mmol/L, from 4th day the standard criteria of the disease compensation were used. Results. Comparison of IIT and traditional approach effectiveness showed that IIT makes better the in-hospital clinical outcomes at earlier stages of MI in DM2.

1. Balabolkin MI, Klebanovа EM. The role of oxidative stress in the pathogenesis of vascular complications of diabetes (lecture). Probl. Endocrinology 2000; 6: 29-33. Russian (Балаболкин М.И., Клебанова Е.М. Роль окислительного стресса в патогенезе сосудистых осложнений диабета (лекция). Пробл. эндокринологии 2000; 6: 29-33).

2. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355(4): 773-8.

3. Fragasso G, Salerno A, Spoladore R, et al. Effects of metabolic approach in diabetic patients with coronary artery disease. Curr Pharm Des 2009; 15(8): 857-62.

4. Fedotova AI, Katkov VA, Maximov IV, Markov VA. The experience of insulin infusion treatment diabetes mellitus patients with acute myocardial infarction. Siberian Medical J 2011; 4; 26(2):132-5. Russian (Федотова А.И., Катков В.А., Максимов И.В., Марков В.А. Опыт применения протокола инфузионной инсулинотерапии в остром периоде инфаркта миокарда у пациентов с сахарным диабетом. Сибирский медицинский ж 2011; 4; 26(2): 132-5).

5. Langley J, Adams G. Insulin-based regimens decrease mortality rates in critically ill patients: a systematic review. Diabetes Metab Res 2007; 184-92.

6. Korobeinikova EN. Modification determination of lipid peroxidation products in the reaction with thiobarbituric acid. Lab Delo 1989; 7: 8-10. Russian (Коробейникова Э.Н. Модификация определения продуктов перекисного окисления липидов в реакции с тиобарбитуровой кислотой. Лабораторное дело 1989; 7: 8-10).

7. Kamyshnikov VS. Handbook of clinical and biochemical laboratory diagnosis. In 2.vol. Minsk.: Belarus. 2000; Vol. 2: 463. Russian (Камышников В.С. Справочник по клинико-биохимической лабораторной диагностике. В 2.т. Мн.: Беларусь 2000; Т 2: 463).

8. Carvajal K, Moreno-Sanchez R. Heart metabolic disturbances in cardiovascular disease. Arch Med Res 2003; 34: 89-99.

9. Bolli R. Oxigen-derivated free radicals and myocardial reperfusion injuri: an overview. Drugs Ther 1991; 5 (2): 249-68.

10. Chaudhuri A, Janicke D, Wilson MF, et al. Anti-inflammatory and pro-fibrinolytic effect of insulin in acute ST-elevation myocardial infarction. Circulation 2004; 109: 849-54.

11. Dandona P, Aljada A, Chaudhuri A, et al. A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation. Circulation 2005; 111:1448-54.

12. Sokolov EI. Lipid peroxidation. In. Diabetic heart. Moscow: Medicine 2002; pp 181-218. Russian (Соколов Е.И. Перекисное окисление липидов. В кн: Диабетическое сердце. М.: Медицина 2002; 181-218).

13. Rebrova TYu, Perchatkin VA, Maximov IV, et al. The protective effect of trimetazidine on the myocardium against reperfusion injury during thrombolytic therapy of acute infarction. Eksp Klin Farmakol. 2004; 67(2): 27-30. Russian (Реброва Т.Ю., Перчаткин В.А., Максимов И.В. и др. Защита миокарда триметазидином от реперфузионных повреждений при тромболитической терапии острого инфаркта миокарда. Экспериментальная и клиническая фармакология 2004; 67(2): 27-30).

14. Szabo Z, Arnqvist H, Hakanson E, et al. Effects of high-dose glucose–insulin–potassium on myocardial metabolism after coronary surgery in patients with type II diabetes. Clin Sci 2001; 101: 37-43.